1. Home
  2. TKO vs LEGN Comparison

TKO vs LEGN Comparison

Compare TKO & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

N/A

Current Price

$212.12

Market Cap

14.5B

Sector

N/A

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$21.50

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKO
LEGN
Founded
1980
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TKO
LEGN
Price
$212.12
$21.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
13
Target Price
$222.31
$69.67
AVG Volume (30 Days)
1.2M
2.7M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
1.48%
N/A
EPS Growth
N/A
N/A
EPS
1.85
N/A
Revenue
$2,545,175,000.00
$909,045,000.00
Revenue This Year
$69.99
$68.83
Revenue Next Year
$29.75
$51.27
P/E Ratio
$113.56
N/A
Revenue Growth
N/A
74.75
52 Week Low
$133.07
$21.51
52 Week High
$213.23
$45.30

Technical Indicators

Market Signals
Indicator
TKO
LEGN
Relative Strength Index (RSI) 72.49 20.03
Support Level $201.60 $26.43
Resistance Level $209.73 $28.97
Average True Range (ATR) 5.83 1.25
MACD 1.70 -0.41
Stochastic Oscillator 85.54 0.73

Price Performance

Historical Comparison
TKO
LEGN

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events, sponsorship, and consumer products licensing agreements of UFC-branded products.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: